Your institution may have access to this item. Find your institution then sign in to continue.
Title
Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of <sup>225</sup>Ac-DOTA-rituximab using <sup>64</sup>Cu-DOTA-rituximab.